Authors : Akpan, Idongesit Samuel; Forwah Jacques Ndeh; Otti Chidiebere Joel; Akaba Kingsley Onoride; Emekwue Chukwudi Alexe; Immaculate Ihuoma Ekeagbaf; Okwu Prudence Chiderag; Umah Victor Umahh; Ujugwe Uchechi Priscillai; Chikwesiri Peace Ugwujahj

Volume/Issue : Volume 10 - 2025, Issue 6 - June

Google Scholar : https://tinyurl.com/6ybem2jd

DOI : https://doi.org/10.38124/ijisrt/25jun405

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Background: Blood transfusion is a critical medical intervention in pediatric patients with various hematological conditions .Ensuring compatibility between donor and recipient blood types is crucial to prevent adverse conditions. However, studies have shown that the acceptable specific indicative criteria for blood transfusion among children with different ABO/Rhesus blood types may not be the same for every patient. More studies have poised that the acceptable specific indicative criteria for blood transfusion vary from one patient to another depending on their specific blood types and associated outcomes which may also depend on the risk factors of adverse reactions and complications which might not be well established.  Objective: This systematic review is aimed at conducting a systematic review of published literature to identify and synthesize acceptable specific criteria of blood transfusion indications among children with different ABO/Rhesus blood types and associated outcomes.  Methods: A comprehensive literature search was conducted across multiple databases using ten different search engines, including PubMed, Scopus, and Web of Science, Google Scholar, Embase, Cochrane Library, CINAHL, PsycINFO, ScienceDirect, ProQuest to identify relevant studies published in English. Out of 400 articles retrieved, 300 articles were selected for inclusion in this review  Results: A total of 400 articles were included in the review, encompassing 300 articles The results of this review showed that the acceptable specific indicative criteria of blood transfusion among children with different ABO/Rhesus blood types varied widely. The findings suggest that blood transfusion acceptable specific and general indicative criteria among children vary depending on ABO and Rh blood types, clinical conditions, and laboratory parameters. Children with blood group type O,B,A and AB positive were more likely to receive blood transfusions, while those with blood group A, B, AB , and O negative were less likely. Acceptable generalized clinical criteria for blood transfusion indications include severe anemia, surgery, trauma, and sickle cell diseases, significant blood loss, and specific hemoglobin thresholds.  Conclusion: This systematic review provides a comprehensive overview of acceptable specific and generalized criteria for blood transfusion indications in children with different ABO and Rh blood types. The findings highlight the importance of considering individual patient needs, clinical conditions, and laboratory parameters and associated outcomes when making transfusion decisions for the benefits of blood transfusions in children population .

Keywords : Specific Indicative Criteria, General Indicative Criteria, Blood Transfusion, Children, ABO/Rh Blood Types.

References :

1. Anstee, D. J., Tanner, M. J. A., & Daniels, G. (2022). The structure and function of red cell membrane proteins. In Blood Groups in Medicine (pp. 47-64). CRC Press.
2. Bolton-Maggs, P. H. B., Poles, D., Watt, A., Thomas, D., & Cohen, H. (2022). Serious hazards of transfusion (SHOT) haemovigilance and the UK haemovigilance network. Transfusion Medicine, 32(2), 147-155. doi: 10.1111/tme.12814
3. Bramer WM, Giustini D, de Jonge GB, Holland L, Bekhuis T. (2016).De-duplication of database search results for systematic reviews in EndNote. J Med Libr Assoc. 104(3):240-3.
4. Bramer WM, Giustini D, Kramer BMR.2017. Searching for studies: a guide to information retrieval for Campbell Systematic Reviews. Campbell Systematic Reviews,13(1):1-66.
5. Carson JL, Grossman BJ, Kleinman S, et al. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2012;157(1):49-58.
6. Cholette JM, Henrichs KF, Alfieris GM, et al. (2018).Washing red blood cells and platelets transfused in cardiac surgery decreases hyperinflammation and improves outcomes. J Thorac Cardiovasc Surg.;156(2):587-597.e2.
7. Chou, S. T., Alsawas, M., & Josephson, C. D. (2020). Transfusion medicine and hemoglobinopathies. Hematology/Oncology Clinics of North America, 34(3), 555-569. doi: 10.1016/j.hoc.2020.01.006
8. Cook DJ, Mulrow CD, Haynes RB.,(1997). Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med. 1997;126(5):376-380.
9. Crowther, M. A., McKenzie, C., & Koscielny, J. (2021). Prevention of RhD alloimmunization in pregnancy. Journal of Thrombosis and Haemostasis, 19(10), 2459-2466.
10. Crowther, M. A., McKenzie, C., & Koscielny, J. (2021). Prevention of RhD alloimmunization in pregnancy. Journal of Thrombosis and Haemostasis, 19(10), 2459-2466.
11. Dean, L. (2021). Blood groups and red cell antigens. Bethesda, MD: National Center for Biotechnology Information.
12. Deeks JJ, Higgins JPT, Altman DG. 2011. Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. The Cochrane Collaboration; 2011.
13. Egger M, Smith GD, Altman DG. 2001,Systematic reviews in health care: meta-analysis in context. 2nd ed. London: BMJ Publishing Group; 2001.
14. Flegel, W. A. (2020). ABO blood group system: A review. Transfusion Medicine and Hemotherapy, 47(2), 137-146. doi: 10.1159/000506364
15. Gauvin F, Lacroix J, Robillard P, et al.,(2017). Acute transfusion reactions in pediatric intensive care unit. Pediatr Crit Care Med. 2017;18(5):433-441.
16. Goel R, Kumar R, Gupta PK, et al.,(2019).Red blood cell transfusion in pediatric patients: a review. J Pediatr Hematol Oncol.;41(3):e143-e148.
17. Haddaway NR, Collins AM, Coughlin D, Kirk S.( 2017).The use of systematic reviews in environmental health. Environ Health.;16(1):111 
18. Haddaway NR, Graça P, Grelle C, et al.,(2022). Assessing the usefulness of Google Scholar as a tool for systematic reviews. Syst Rev.,11(1):104.
19. Haddaway NR, Page MJ, Pritchard CC, McGuinness LA. (2022) .PRISMA 2020: A reporting guideline for systematic reviews. Campbell Syst Rev.;18(1):e1238.
20. Higgins JPT, Green S. Cochrane,(2011). Handbook for Systematic Reviews of Interventions. Version 5.1.0. The Cochrane Collaboration.
21. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al., (2019) .Cochrane Handbook for Systematic Reviews of Interventions. 2nd ed. Chichester (UK): John Wiley & Sons.
22. Karam O, Tucci M, Ducruet T, et al.,(2017).Red blood cell transfusion in pediatric trauma patients. J Pediatr Surg.;52(1):141-146.
23. Kneyber MC, van Woensel JB, Brunsveld JE, et al.,(2016).Blood transfusion in pediatric critical care: a prospective observational study. Pediatr Crit Care Med.;17(5):433-441.
24. Kumar, P., Henrichs, K. F., & Maslak, P. (2022). Blood transfusion in pediatric patients: Current concepts and future directions. Journal of Clinical Medicine, 11(11), 2881. doi: 10.3390/jcm11112881
25. Lacroix J, Hebert PC, Hutchison JS, et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med. 2007;356(16):1609-1619.
26. Lefebvre C, Manheimer E, Glanville J. (2011).Searching for studies. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. The Cochrane Collaboration.
27. Liumbruno, G. M., & Velati, C. (2020). Blood group systems and their relevance for transfusion medicine. Blood Transfusion, 18(3), 158-166.
28. Moher D, Liberati A, Tetzlaff J, Altman DG, (2003).The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. 2009;6(7):e1000097.
29. Oxman AD, Cook DJ, Guyatt GH. Users' guides to the medical literature. VI. How to use an overview. JAMA. 1994;272(17):1367-1371.
30. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al.,( 2021).The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ.; 372:n71.
31. Page MJ, Moher D, Bossuyt PM, et al.,(2021).PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ.;372:n160.
32. Patel SR, Patel P, Kumar A, et al.,(2020). Blood transfusion in pediatric patients: a prospective study. J Pediatr Hematol Oncol.;42(1):e1-e8.
33. PRISMA Group. 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med.,6(7):e1000097
34. Reid, M. E., & Lomas-Francis, C. (2020). The Blood Group Antigen FactsBook. Academic Press.
35. Sazama, K., & DeChristopher, P. J. (2022). Adverse reactions to blood transfusion. In Transfusion Medicine and Hemostasis (pp. 567-574). Elsevier.
36. Storch, E. K., Cancio, L. C., & Spinella, P. C. (2020). Blood transfusion in trauma. Critical Care Clinics, 36(2), 271-285.
37. Stroup DF, Berlin JA, Morton SC, et al.,2000. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283(15):2008-2012.    
38. Tricco AC, Langlois EV, Straus SE. (2016). A scoping review on the conduct and reporting of scoping reviews. BMC Med Res Methodol. ;16(1):15
39. Tricco AC, Lillie E, Zarin W, et al.,(2018).PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med.;169(7):467-473
40. Valentine SL, Bembea MM, Muszynski JA, et al. Consensus recommendations for RBC transfusion practice in critically ill children. Pediatrics. 2018;142(3):e20180566.
41. Wang WK, Lin SR, Lee CM, et al.,(2018).Blood transfusion in children: a review of the literature. J Pediatr Hematol Oncol. 2018;40(3):e143-e148.
42. Westhoff, C. M., Reid, M. E., & King, K. E. (2020). Blood group antigens and antibodies. In Transfusion Medicine and Hemostasis (pp. 33-40). Elsevier.
43. Zipper, S. G., Tripathi, A., & Ramsey, G. (2022). Hemolytic disease of the fetus and newborn. Journal of Perinatal Medicine, 50(5), 546-554.